Results 51 to 60 of about 8,209 (172)
Kikuchi-Fujimoto Disease in Pediatrics
Background: Kikuchi-Fujimoto Disease (KFD)11 KFD: Kikuchi-Fujimoto Disease. is a rare, benign, idiopathic, and self-limiting lymphadenitis typically affecting head and neck regions.
Erna Kristiani +4 more
doaj +1 more source
The glycolipid‐peptide antigen complexes for self‐adjuvanting conjugates were successfully synthesized, and, with the HLA‐transgenic mice, the antigen‐specific CD8+ T cell expansion was exhibited. The results provide useful insights for the design and synthesis of vaccine conjugates using glycolipid antigen as an adjuvant.
Shunya Kikuchi +4 more
wiley +1 more source
Hodgkin lymphoma misdiagnosed as Kikuchi-Fujimoto disease – how important it is to confirm an unusual diagnosis [PDF]
Kikuchi-Fujimoto disease (KFD) is an extremely rare, self-limiting disorder of unknown etiology, with most cases occurring in Asia. The treatment of KFD is mainly supportive with NSAIDs or steroids in isolated cases.
Piotr Krych, Wiktoria Grcuk
core +2 more sources
ABSTRACT Introduction Upper tract urothelial carcinoma with neuroendocrine differentiation (UC‐NE) is extremely rare and generally associated with aggressive behavior and poor prognosis. Optimal treatment strategies remain unclear, particularly regarding the role of nectin‐4–targeted therapy. Case Presentation A 61‐year‐old man was diagnosed with UC‐NE
Kosei Taniguchi +9 more
wiley +1 more source
[Kikuchi-Fujimoto disease]. [PDF]
Kikuchi-Fujimoto disease is a necrotizing lymphadenitis, involving young patients, predominantly females. Lymphadenopathy is usually localized, particularly in the cervical area, mostly unilateral and tender. Fever is present in one third of cases. Associated skin lesions, arthralgia, myalgia, splenomegaly or hepatomegaly are rare.
openaire +3 more sources
Immortal time bias (ITB)–adjusted landmark and time‐dependent Cox analyses showed that immune‐related adverse events (irAEs) were not associated with improved survival in NSCLC patients receiving first‐line immune checkpoint inhibitors. ECOG performance status remained the key prognostic factor.
Yoshiki Kuwabara +20 more
wiley +1 more source
Kikuchi–Fujimoto disease manifesting bilateral lymphadenopathy
Physicians should keep in mind that Kikuchi‐Fujimoto disease can show bilateral lymphadenopathy like the present case.
Akihiro Kawatsuki +3 more
doaj +1 more source
Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures
Background Kikuchi-Fujimoto disease, known as histiocytic necrotizing lymphadenitis, is a benign, self-limiting and systemic disorder involving lymph nodes with unknown aetiology.
Shenjie Xu, Weilian Sun, Jiamei Liu
doaj +1 more source
Role of growth factors in the pathogenesis of tissue fibrosis in systemic sclerosis. [PDF]
The most severe clinical and pathologic manifestations of systemic sclerosis (SSc) are the result of a fibrotic process characterized by the excessive and often progressive deposition of collagen and other connective tissue macromolecules in skin and ...
Castro, Susan V. +2 more
core +2 more sources
Kikuchi–Fujimoto Disease Presenting With Complex Neurological Manifestations: A Case Report
Kikuchi–Fujimoto Disease (KFD) is a rare, typically self‐limiting inflammatory condition primarily associated with fever, cervical lymphadenopathy, and occasionally small‐vessel vasculitis. Central nervous system (CNS) involvement in KFD is exceedingly rare and has been described in isolated cases, including encephalitis, aseptic meningitis, and ...
Yusuf Kagzi +5 more
wiley +1 more source

